Microbot Medical Inc MBOT
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $1.07
- Day Range
- $1.05–1.09
- 52-Week Range
- $1.05–3.17
- Bid/Ask
- $1.06 / $1.11
- Shares Outstanding
- 67.16M
- Market Cap
- $71.87M
- Volume/Avg
- 637,699 / 647,741
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 193.18
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Microbot Medical Inc is a medical device company specializing in the research, design, and development of next-generation robotic endoluminal surgery devices targeting the minimally invasive surgery space. Using its LIBERTY technological platform, the company has developed the LIBERTY Endovascular Robotic Surgical System, a fully disposable robot for various endovascular interventional procedures. The company has a single operating and reportable segment, which is the development of robotic devices for endoluminal surgery.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Core
- Total Number of Employees
- 22
- Website
- https://www.microbotmedical.com
Valuation
|
Metric
|
MBOT
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 1.04 |
Price/Sales | 193.18 |
Price/Cash Flow | — |
Price/Earnings
MBOT
Financial Strength
|
Metric
|
MBOT
|
|---|---|
Quick Ratio | 17.37 |
Current Ratio | 18.56 |
Interest Coverage | — |
Quick Ratio
MBOT
Profitability
|
Metric
|
MBOT
|
|---|---|
Return on Assets (Normalized) | −21.73% |
Return on Equity (Normalized) | −22.97% |
Return on Invested Capital (Normalized) | −25.97% |
Return on Assets
MBOT
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| LOCK|%fs@g? | LOCK|%wl? | $172B | |||
| Medtronic PLC
MDT
| LOCK|YM%#RR! | LOCK|p@qFb | $113B | |||
| Stryker Corp
SYK
| LOCK|%Rn&^ZN | LOCK|?G | $106B | |||
| Boston Scientific Corp
BSX
| LOCK|V!PLS> | LOCK|@!Dg | $62B | |||
| Edwards Lifesciences Corp
EW
| LOCK|#cq&^N!G | LOCK|s&k#W | $49B | |||
| DexCom Inc
DXCM
| LOCK|&d!dwr%? | LOCK|n<<^ | $32B | |||
| GE HealthCare Technologies Inc Common Stock
GEHC
| LOCK|%^^mP%C | LOCK|KVy | $30B | |||
| Koninklijke Philips NV ADR
PHG
| LOCK|Sg< | LOCK|ck | $24B | |||
| Steris PLC
STE
| LOCK|T?<j?>! | LOCK|>n#Zw | $21B | |||
| Zimmer Biomet Holdings Inc
ZBH
| LOCK|<kR>QBvQ | LOCK|<^g | $17B |
United States